Systemic corticosteroid therapy for acute asthma exacerbations.

Area of Science:

• Pulmonology
• Allergy and Immunology
• Clinical Pharmacology

Background:

• Acute asthma exacerbations pose significant patient and societal costs due to emergency department visits and hospitalizations.
• These episodes can lead to severe illness and mortality, underscoring the need for effective management strategies.
• Corticosteroids are a fundamental treatment for asthma, proven to decrease admission rates and prevent relapses.

Purpose of the Study:

• To provide an overview of corticosteroid use in acute asthma exacerbations.
• To guide effective decision-making regarding the choice of corticosteroid therapy.
• To highlight the role of corticosteroids in preventing adverse outcomes and reducing healthcare burden.

Main Methods:

• Review of existing literature on corticosteroid therapy for acute asthma.
• Analysis of the efficacy of various corticosteroids (betamethasone, dexamethasone, methylprednisolone, prednisolone) in managing exacerbations.
• Synthesis of evidence supporting corticosteroid use for reducing morbidity and healthcare utilization.

Main Results:

• Corticosteroids are a cornerstone therapy for acute asthma exacerbations.
• Evidence supports their role in lowering hospital admission rates and reducing the risk of relapse.
• Different corticosteroids offer therapeutic options for managing exacerbations effectively.

Conclusions:

• Optimizing the management of acute asthma exacerbations through appropriate corticosteroid selection is critical.
• Corticosteroids play a pivotal role in improving patient outcomes and mitigating the economic impact of asthma.
• This overview aims to support clinicians in making informed therapeutic choices for acute asthma management.